Keystone to Secure Safety After Stopping Nucleos(t)ide Analogue Therapy in Chronic Hepatitis B Patients Reply

被引:0
作者
Hsu, Yao-Chun [1 ,2 ,3 ,4 ,5 ]
Tseng, Cheng-Hao [3 ,6 ]
Nguyen, Mindie H. [7 ]
机构
[1] E Da Hosp, Ctr Liver Dis, Kaohsiung, Taiwan
[2] E Da Hosp, Dept Med Res, Kaohsiung, Taiwan
[3] I Shou Univ, Coll Med, Sch Med, Kaohsiung, Taiwan
[4] Fu Jen Catholic Univ Hosp, Dept Internal Med, New Taipei, Taiwan
[5] Natl Yang Ming Chiao Tung Univ, Inst Biomed Informat, Taipei, Taiwan
[6] E Da Canc Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Kaohsiung, Taiwan
[7] Stanford Univ, Med Ctr, Dept Epidemiol & Populat Hlth, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA
关键词
D O I
10.1016/j.cgh.2021.10.026
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1891 / 1892
页数:2
相关论文
共 8 条
[1]   Severe Acute Exacerbation After Cessation of Nucleos(t)ide Analog for Chronic Hepatitis B: A Real-World Study of Routine Practice [J].
Hsu, Yao-Chun ;
Wu, Jia-Ling ;
Tseng, Cheng-Hao ;
Nguyen, Mindie H. ;
Lin, Chih-Wen ;
Hung, Chih-Lung .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (06) :1413-+
[2]   Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B [J].
Jeng, Wen-Juei ;
Chen, Yi-Cheng ;
Chien, Rong-Nan ;
Sheen, I-Shyan ;
Liaw, Yun-Fan .
HEPATOLOGY, 2018, 68 (02) :425-434
[3]  
Lewin A, 2018, EPIDEMIOLOGY, V29, P87, DOI [10.1097/EDE.0000000000000755, 10.1097/ede.0000000000000755]
[4]   Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment [J].
Ma, Te-Ling ;
Hu, Tsung-Hui ;
Hung, Chao-Hung ;
Wang, Jing-Houng ;
Lu, Sheng-Nan ;
Chen, Chien-Hung .
PLOS ONE, 2019, 14 (10)
[5]   Diagnosis Rates of Chronic Hepatitis B in Privately Insured Patients in the United States [J].
Ogawa, Eiichi ;
Yeo, Yee Hui ;
Dang, Nolan ;
Le, Michael H. ;
Jeong, Donghak ;
Tran, Sally ;
Henry, Linda ;
Cheung, Ramsey ;
Nguyen, Mindie H. .
JAMA NETWORK OPEN, 2020, 3 (04)
[6]   Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis [J].
Tan, Mingjuan ;
Bhadoria, Ajeet S. ;
Cui, Fuqiang ;
Tan, Alex ;
Van Holten, Judith ;
Easterbrook, Philippa ;
Ford, Nathan ;
Han, Qin ;
Lu, Ying ;
Bulterys, Marc ;
Hutin, Yvan .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (02) :106-119
[7]   Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects [J].
Wong, Grace Lai-Hung ;
Tse, Yee-Kit ;
Wong, Vincent Wai-Sun ;
Yip, Terry Cheuk-Fung ;
Tsoi, Kelvin Kam-Fai ;
Chan, Henry Lik-Yuen .
HEPATOLOGY, 2015, 62 (03) :684-693
[8]   Substantial gaps in evaluation and treatment of patients with hepatitis B in the US [J].
Ye, Qing ;
Kam, Leslie Y. ;
Yeo, Yee Hui ;
Dang, Nolan ;
Huang, Daniel Q. ;
Cheung, Ramsey ;
Nguyen, Mindie H. .
JOURNAL OF HEPATOLOGY, 2022, 76 (01) :63-74